Bayesian Capital Management’s Medidata Solutions, Inc. MDSO Stock Holding History

Bayesian Capital Management’s Portfolio MDSO Stock Details MDSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-6,593	Closed	-$516K	–	710
2017 Q2	$516K	Sell	6,593 -800	-11%	-$55.8K	0.19%	179
2017 Q1	$427K	Buy	7,393 +3,100	+72%	+$168K	0.2%	194
2016 Q4	$213K	Buy	+4,293	New	+$223K	0.05%	507
2016 Q3	–	Sell	-6,897	Closed	-$323K	–	578
2016 Q2	$323K	Buy	+6,897	New	+$300K	0.19%	217

Other funds holding MDSO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Bayesian Capital Management's MDSO Position: Q3 2017 in Review

Bayesian Capital Management sold out of Medidata Solutions, Inc. (MDSO) in Q3 2017, closing a stake of 6,593 shares — an estimated $516K sold.

Bayesian Capital Management first reported a position in MDSO in Q2 2016 and held it in 4 quarters. The position peaked at $516K in Q2 2017. 249 funds tracked by Wall St. Rank hold MDSO as of Q3 2017.

Bayesian Capital Management reported no remaining Medidata Solutions, Inc. position as of Q3 2017 after selling out during the quarter.
Bayesian Capital Management sold 6,593 Medidata Solutions, Inc. shares in Q3 2017, an estimated $516K.
Bayesian Capital Management first reported a position in Medidata Solutions, Inc. in Q2 2016 and held it in 4 quarters.
Bayesian Capital Management's Medidata Solutions, Inc. position peaked at $516K in Q2 2017.
249 funds tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q3 2017.

Based on Bayesian Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.